Skip to content

Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001747
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary colic

Interventions

Acupuncture group A:Acupuncture at the Yanglingquan point
Acupuncture group B:Acupuncture at the Xiabai Point
Acupuncture group C:Acupuncture at non-meridian points

Sponsors

Tianjin Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets diagnostic criteria for cholecystitis according to both Chinese and Western medicine; (2) Patients exhibiting clinical manifestations of biliary colic with a Visual Analogue Scale (VAS) score >4; (3) Aged 18 to 65 years; (4) Patients provide informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients meeting criteria for emergency surgery; (2) Patients with psychiatric issues unable to cooperate with treatment; (3) Patients with severe complications such as suppurative cholecystitis, suppurative cholangitis, acute pancreatitis, gallbladder perforation, tumors, or severe infections; (4) Patients with other serious comorbidities including liver, brain, kidney, or cardiovascular diseases; (5) Patients with severe local lesions (e.g., infections, burns, scalds) where acupuncture is contraindicated; (6) Pregnant women and lactating women; (7) Patients with prostatic hypertrophy; (8) Patients who have already undergone other treatment modalities.

Design outcomes

Primary

MeasureTime frame
Simplified McGill Pain Questionnaire (SF-MPQ) Score;Traditional Chinese Medicine Syndrome Scoring;

Secondary

MeasureTime frame
Maximum longitudinal diameter (L) and anterior-posterior diameter (W) of the gallbladder;Common bile duct diameter;Gallbladder wall thickness;Glossiness of the gallbladder;Gallbladder volume;Gallbladder contraction function;Bile flow;Plasma C-reactive protein (CRP);ß-endorphin (ß-EP);Cholcystokinin (CCK) levels;

Countries

China

Contacts

Public ContactZhang Xibo

Tianjin Hospital of Integrated Traditional Chinese and Western Medicine

nkzxb@126.com18630985525

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026